Literature DB >> 26567624

Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer.

Tapan Kumar Giri1, Ayan Giri, Tapan Kumar Barman, Subhasis Maity.   

Abstract

Nano-liposomes are the newly developed delivery systems for cancer therapy that are finding a position particularly suitable as peptide and protein carriers. These are three-layered self-assembled structures with nanoparticulate carrier systems. The overall pharmacological properties of commonly used protein and peptide in cancer therapy can be improved by the incorporation of protein and peptide into the nano-liposome. The surface modifications can be made liposomes to make compatible with targeting ligands has made these nanocarriers for targeted delivery. This review discusses the method of preparation and characterization of liposome based protein peptide delivery for the treatment of cancer. This review also explores latest work intended for targeted treatment of cancer by nano-liposomal protein and peptide delivery system. This type of delivery is targeting protein and peptide to tumor site by avoiding the reticuloendothelial system. Methods of nano-liposome delivery containing protein and peptide are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26567624     DOI: 10.2174/1871520616666151116121821

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  7 in total

Review 1.  Clinical Translation of the National Institutes of Health's Investments in Nanodrug Products and Devices.

Authors:  Lori A Henderson; Lalitha K Shankar
Journal:  AAPS J       Date:  2016-12-19       Impact factor: 4.009

Review 2.  Mannose: A Sweet Option in the Treatment of Cancer and Inflammation.

Authors:  Fang Nan; Yutong Sun; Hantian Liang; Jingyang Zhou; Xiao Ma; Dunfang Zhang
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

Review 3.  Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application.

Authors:  Domenico Lombardo; Mikhail A Kiselev
Journal:  Pharmaceutics       Date:  2022-02-28       Impact factor: 6.321

4.  Targeting PEPT1: a novel strategy to improve the antitumor efficacy of doxorubicin in human hepatocellular carcinoma therapy.

Authors:  Yanxia Gong; Xiang Wu; Tao Wang; Jia Zhao; Xi Liu; Zhi Yao; Qingyu Zhang; Xu Jian
Journal:  Oncotarget       Date:  2017-06-20

Review 5.  Current applications and prospects of nanoparticles for antifungal drug delivery.

Authors:  Sanam Nami; Ali Aghebati-Maleki; Leili Aghebati-Maleki
Journal:  EXCLI J       Date:  2021-03-08       Impact factor: 4.068

6.  Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy.

Authors:  Mingming Song; Wentao Xia; Zixuan Tao; Bin Zhu; Wenxiang Zhang; Chang Liu; Siyu Chen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Preparation, Characterization, and Anticancer Effects of Capsaicin-Loaded Nanoliposomes.

Authors:  Ali Al-Samydai; Walhan Alshaer; Emad A S Al-Dujaili; Hanan Azzam; Talal Aburjai
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.